Microbiota–brain axis: Context and causality from Sarkis Mazmanian & I in Science Magazine science.org/doi/10.1126/sc…

A wonderful overview of how microbe-host interactions can be harnessed to modulate brain function.

Dr. Roland Griffiths, David Lawrence, MD MPH, Robin Carhart-Harris, and Chris Timmermann recently published a study that provided a quantitative analysis of the content of DMT experiences over a 10-year period. (1/6) nature.com/articles/s4159…

Antidepressant ketamine: scRNAseq in ventral hippocampus suggests that the voltage-gated potassium channel Kcnq2 is a downstream target. Co-administration of a KCNQ activator augments the antidepressant effects in mice! alon_chen_lab Neuron sciencedirect.com/science/articl…

A wonderful commentary on the question that plagues #microbiome-science, causation vs correlation... is the microbiota truly the master manipulator, or just there for the ride? John F. Cryan science.org/doi/epdf/10.11…

For anyone starting their journey in microbiome analysis, this read is a must! Written by some of the leading experts in bioinformatics and gut-brain axis research. Thomaz Bastiaanssen, PhD

New paper on "Effective connectivity of functionally anticorrelated networks under #LSD" is published! Awesome work by Adeel Razi and Devon Stoliker. biologicalpsychiatryjournal.com/article/S0006-…

Interested in exploring the mechanisms and #microbialmetabolites underpinning #stress and brain-gut-microbiome interactions? Then great postdoc opportunity for you in #clarkelab #cryanlab John F. Cryan APC Microbiome Ireland job id 059191 my.corehr.com/pls/uccrecruit…

Question for my fellow psychedelic researchers: why is it that in most/all clinical trials, participants are given two doses of psilocybin, a few weeks apart? Would one dose not be sufficient to elicit an (antidepressant) effect?

MAPS Completes Second Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD According to the clinical trial registry entry, 121 participants were recruited and the study was completed on November 2nd. Slightly ahead of the estimated completion date.

Let's go!

Delighted to share our new paper looking at the psychotherapeutic and neurobiological processes associated with ayahuasca. Here we propose a therapeutic model as well as implications for therapeutic use. Enjoy! frontiersin.org/articles/10.33… Psychae Institute Jerome Sarris Tessa Cowley-Court

✨ TEAM THURSDAYS (or something more catchy...)✨ As well as working on our research, Giorgia Caspani is a psychedelic postdoc at University of British Columbia 🇨🇦 after getting her PhD at @ImperialCollege She specialises in microbiota-gut-brain axis, metabolites & biomarkers, esp. for depression 🧠

Momentum continues to build at @Onaya_Science, as our website has had a big upgrade! At onaya.science you can see all of our ayahuasca research (past and present), team profiles, reciprocity efforts and ways to get in touch with the team 🙏🏻

Fascinating work and beautifully narrated. More and more evidence is emerging for an active role of microglia in many neurological disorders.

Excited to share our latest review paper on the interaction between psychedelics and the gut-brain axis, with some thoughts on how this knowledge can inform precision medicine. Thanks to the team at Onaya, Michael Smith Labs and Jon Swann sciencedirect.com/science/articl…

Happening today 16:00 BST

Nice little infographic thread of our new paper (1st author Giorgia Caspani) courtesy of Onaya! ✳️ Psychedelics and the Gut ✳️ ... (1/7)

Our NEW #RESEARCHPAPER opens the possibility for individualised psychedelic -assisted treatments based on someone’s unique gut microbiome. Read the full paper: onaya.science/research Giorgia Caspani Simon Ruffell WaiFung Tsang Nige Netzband #guthealth #microbiome #mentalhealth

In this episode of the Psychedelic Medicine Podcast, Giorgia Caspani, PhD joins to discuss the intersection of #psychedelics and the gut #microbiome and ramifications for future personalized medicine. open.spotify.com/episode/3dq3Ar…